Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Clinical Study of Pulsed, Inhaled Nitric Oxide Versus Placebo in Symptomatic Subjects With PAH

ClinicalTrials.gov ID: NCT02725372

Public ClinicalTrials.gov record NCT02725372. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 12:34 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Placebo Controlled, Double-Blind, Randomized, Clinical Study to Determine Efficacy, Safety, and Tolerability of Pulsed, Inhaled Nitric Oxide (iNO) Versus Placebo in Symptomatic Subjects With PAH (Part 1 and Part 2)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Phase 3, placebo controlled, double-blind, randomized clinical study to determine safety, tolerability, and efficacy of pulsed, inhaled nitric oxide (iNO) versus placebo in symptomatic subjects with pulmonary arterial hypertension (PAH). Part 1 and Part 2

Study identification

NCT ID
NCT02725372
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bellerophon Pulse Technologies
Industry
Enrollment
207 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2016
Primary completion
Jul 31, 2018
Completion
Jul 31, 2018
Last update posted
Feb 20, 2023

2016 – 2018

United States locations

U.S. sites
37
U.S. states
18
U.S. cities
36
Facility City State ZIP Site status
Arizona Pulmonary Specialists, Ltd Phoenix Arizona 85012
University of Arizona Sarver Heart Center Tucson Arizona 85724-5046
Cedars-Sinai Medical Center Beverly Hills California 90211
UC San Diego / Pulmonary, Critical Care and Sleep Medicine Division La Jolla California 92093
West Los Angeles VA Healthcare Center Los Angeles California 90073
University of California, Davis Medical Center Sacramento California 95817
University of Colorado Denver Aurora Colorado 80045
Pulmonary Disease Specialists, PA Kissimmee Florida 34741
Central Florida Pulmonary Group, PA Orlando Florida 32803-5727
Cleveland Clinic Florida Weston Florida 33331
Pulmonary and Critical Care of Atlanta Atlanta Georgia 30342
Piedmont Healthcare Pulmonary and Critical Care Research Austell Georgia 30106
Wellstar Medical Group - Pulmonary Medicine Marietta Georgia 30060
Bluhm Cardiovascular Institute, Clinical Trials Unit Chicago Illinois 60611
HeartCare Midwest Peoria Illinois 61616
Kentuckiana Pulmonary Associates (KPA), Inc. - Louisville Louisville Kentucky 40202-1332
Brigham and Women's Hospital Boston Massachusetts 02115
University of Nebraska Medical Center Omaha Nebraska 68198-5590
Albany Medical Center Albany New York 12208
New York Presbyterian Brooklyn Methodist Hospital - Division of Pulmonary/Critical Care/Sleep Brooklyn New York 11215
Winthrop University Hospital, Clinical Trials Center Mineola New York 11501
NYU Medical Center, Division Pulmonary, Critical Care and Sleep Medicine New York New York 10279
Montefiore Medical Center - Weiler Division The Bronx New York 10461
University of Cincinnati Medical Ctr, Dept of Internal Medicine / Pulmonary, Critical Care & Sleep Medicine Cincinnati Ohio 45267-0564
Cleveland Clinic Cleveland Ohio 44195
The Ohio State University Columbus Ohio 43065
Legacy Medical Group - Pulmonary Clinic Portland Oregon 97210
The Oregon Clinic, PC Portland Oregon 97220
Temple University Hospital Philadelphia Pennsylvania 19140
Allegheny Singer Research Institute Pittsburgh Pennsylvania 15212
Medical University of South Carolina Charleston South Carolina 29425
MedTrial, LLC Columbia South Carolina 29204
Sioux Falls Cardiovascular Sioux Falls South Dakota 57108
University of Texas Southwestern Medical Center of Dallas Dallas Texas 75390-8550
Pulmonary Associates of Richmond Richmond Virginia 23229
University of Wisconsin Madison Wisconsin 53792-1615
Medical College of Wisconsin Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 72 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02725372, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 20, 2023 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02725372 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →